| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
193,294 |
173,036 |
$13.99M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
108,759 |
107,330 |
$9.38M |
| S9083 |
Global fee urgent care centers |
81,536 |
72,495 |
$8.04M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
43,134 |
40,632 |
$3.79M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
32,568 |
29,848 |
$2.46M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
67,446 |
61,549 |
$1.81M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14,764 |
14,670 |
$1.54M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
22,940 |
20,871 |
$991K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12,877 |
12,799 |
$819K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
106,480 |
100,303 |
$615K |
| 99441 |
|
11,822 |
11,012 |
$586K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
21,546 |
10,974 |
$186K |
| 87070 |
|
25,404 |
24,150 |
$164K |
| 87276 |
|
7,165 |
6,987 |
$60K |
| 87275 |
|
7,132 |
6,957 |
$58K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,452 |
2,403 |
$48K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
185 |
184 |
$46K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,626 |
2,532 |
$39K |
| 12001 |
|
634 |
618 |
$38K |
| 99050 |
|
7,693 |
7,531 |
$34K |
| 73630 |
|
2,587 |
2,487 |
$29K |
| 29125 |
|
727 |
701 |
$28K |
| 71046 |
Radiologic examination, chest; 2 views |
1,980 |
1,911 |
$26K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
466 |
448 |
$24K |
| 73110 |
|
1,814 |
1,734 |
$24K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
605 |
558 |
$19K |
| 73130 |
|
1,373 |
1,315 |
$18K |
| 99442 |
|
204 |
194 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,096 |
2,986 |
$15K |
| 73610 |
|
1,262 |
1,210 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
10,670 |
10,467 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
298 |
294 |
$12K |
| 96127 |
|
6,703 |
6,227 |
$11K |
| 90686 |
|
666 |
661 |
$11K |
| 29130 |
|
546 |
521 |
$10K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
604 |
599 |
$10K |
| 90658 |
|
692 |
692 |
$9K |
| 0011A |
|
185 |
184 |
$8K |
| Q4049 |
Finger splint, static |
267 |
265 |
$7K |
| 81002 |
|
5,344 |
5,100 |
$6K |
| 73140 |
|
839 |
800 |
$6K |
| 93000 |
|
543 |
533 |
$6K |
| 99051 |
|
9,389 |
8,830 |
$5K |
| 12011 |
|
66 |
66 |
$5K |
| 81025 |
|
2,978 |
2,858 |
$5K |
| 99000 |
|
18,922 |
17,812 |
$5K |
| 99072 |
|
5,848 |
5,388 |
$5K |
| 25600 |
|
34 |
33 |
$5K |
| 0012A |
|
71 |
71 |
$4K |
| 99001 |
|
37,553 |
32,474 |
$4K |
| 73080 |
|
288 |
273 |
$4K |
| 10121 |
|
17 |
16 |
$3K |
| 10060 |
|
71 |
70 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
481 |
427 |
$3K |
| 10120 |
|
40 |
40 |
$3K |
| 0002A |
|
52 |
52 |
$2K |
| 69210 |
|
102 |
94 |
$2K |
| 0001A |
|
40 |
40 |
$2K |
| 0031A |
|
44 |
43 |
$2K |
| 90688 |
|
539 |
445 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
7,127 |
6,544 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
115 |
111 |
$1K |
| 73090 |
|
128 |
122 |
$1K |
| 73562 |
|
87 |
76 |
$943.87 |
| 73590 |
|
56 |
56 |
$734.25 |
| 99443 |
|
416 |
416 |
$404.65 |
| 0013A |
|
18 |
18 |
$313.35 |
| S8431 |
Compression bandage, roll |
65 |
64 |
$297.50 |
| 87807 |
|
13 |
13 |
$264.30 |
| 86618 |
|
12 |
12 |
$238.47 |
| 90715 |
|
12 |
12 |
$233.62 |
| 82962 |
|
92 |
87 |
$231.40 |
| 80305 |
|
34 |
34 |
$175.82 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
13 |
13 |
$123.20 |
| 85027 |
|
24 |
22 |
$115.20 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
19 |
18 |
$104.24 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
26 |
24 |
$86.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$59.61 |
| 90694 |
|
28 |
21 |
$30.50 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
16 |
15 |
$26.46 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16 |
15 |
$26.45 |
| 1125F |
|
11,332 |
10,398 |
$9.01 |
| 1160F |
|
9,283 |
8,233 |
$1.00 |
| 1126F |
|
454 |
412 |
$1.00 |
| 1159F |
|
758 |
661 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
164 |
161 |
$0.00 |
| 99080 |
|
61 |
46 |
$0.00 |
| A4565 |
Slings |
35 |
35 |
$0.00 |
| 3008F |
|
708 |
632 |
$0.00 |
| A7015 |
Aerosol mask, used with dme nebulizer |
40 |
38 |
$0.00 |
| 71020 |
|
71 |
70 |
$0.00 |